Medication Adherence in Older Adults With Serious Mental Illness

NCT00224380 | Completed

• 1 other identifier: MA200316456
• Study Type: interventional
• Target: 72
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this pilot study is to learn about how well older people with serious mental illness (including schizophrenia, schizoaffective disorder, bipolar disorder, major depression) follow prescribed medication regimens, and to evaluate a manualized intervention designed to enhance medication management skills and adherence, the Using Medications Effectively program. The following four hypotheses will be tested:

1. 1.Medication adherence will be associated with several variables including insight, memory, medication management skill, knowledge about medications, attitudes about medications.
2. 2.People who receive the program will have better medication adherence compared to those who do not receive the program as measured by pill counts.
3. 3.People who receive the program will develop better medication management skills compared to those who do not receive the program.

Conditions

Schizophrenia; Bipolar Disorder; Depression

Keywords

Serious mental illness; medication adherence

Outcome Measures

Primary Outcomes (1)

• Medication adherence based on pill counts

Secondary Outcomes (1)

• Medication management ability

Interventions

Using Medications Effectively BEHAVIORAL

Eligibility Criteria

• Age: 50 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Participation in Rehabilitation and Health Care for Older People with SMI Serious mental illness (schizophrenia, schizoaffective disorder, bipolar disorder, major depression) and functional impairment Receiving mental health services for 3 months or more Age 50 or older Ability to provide informed consent or guardian consent -

You may not qualify if:

• Currently residing in an institution Psychiatric illness caused by co-morbid medical condition Dementia or score\<20 on Mini Mental State Exam

Sponsors & Collaborators

• Dartmouth-Hitchcock Medical Center: lead
• Janssen, LP: collaborator
• National Alliance for Research on Schizophrenia and Depression: collaborator

Study Sites (1)

Community Council of Nashua

Nashua, New Hampshire, 03063, United States

Location

MeSH Terms

Conditions

Schizophrenia; Bipolar Disorder; Depression; Medication Adherence

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic Disorders; Mental Disorders; Bipolar and Related Disorders; Mood Disorders; Behavioral Symptoms; Behavior; Patient Compliance; Patient Acceptance of Health Care; Treatment Adherence and Compliance; Health Behavior

Study Officials

• Sarah I Pratt, PhD

  Assistant Professor in Psychiatry, Dartmouth Medical School

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER

Study Record Dates

• First Submitted: September 15, 2005
• First Posted: September 23, 2005
• Study Start: July 1, 2003
• Study Completion: February 1, 2005
• Last Updated: September 23, 2009

Record last verified: 2009-09

Locations

US (1)